lumigan
Showing 1 - 3 of 3
Open Angle Glaucoma, Ocular Hypertension Trial (SDP-133, Lumigan)
Withdrawn
- Open Angle Glaucoma
- Ocular Hypertension
- SDP-133
- Lumigan
- (no location specified)
Nov 18, 2021
Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost SR, LUMIGAN)
Completed
- Open-Angle Glaucoma
- Ocular Hypertension
- Bimatoprost SR
- LUMIGAN
-
Dothan, Alabama
- +5 more
May 17, 2022
Open-angle Glaucoma, Ocular Hypertension Trial in Japan, United States (AGN-193408 SR, Lumigan, Sham Administration)
Recruiting
- Open-angle Glaucoma
- Ocular Hypertension
- AGN-193408 SR
- +3 more
-
Inglewood, California
- +27 more
Oct 4, 2022